Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 3 of 3 entries
Sorted by: Best Match Show Resources per page
The association of body mass index with quality of life and working ability: a Finnish population-based study.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Vesikansa A, Mehtälä J, Jokelainen J, Mutanen K, Lundqvist A, Laatikainen T, Ylisaukko-Oja T, Saukkonen T, Pietiläinen KH.
PMID: 34533758
Qual Life Res. 2021 Sep 17; doi: 10.1007/s11136-021-02993-0. Epub 2021 Sep 17.

PURPOSE: The impact of obesity on quality of life (QoL) and working ability vary in different dimensions. This study investigated the association of obesity with QoL and working ability in Finnish adults. Comorbidities as associative factors were also characterised.METHODS:...

Cite
Vesikansa A, Mehtälä J, Jokelainen J, et al. The association of body mass index with quality of life and working ability: a Finnish population-based study. Qual Life Res. 2021;doi: 10.1007/s11136-021-02993-0.
Vesikansa, A., Mehtälä, J., Jokelainen, J., Mutanen, K., Lundqvist, A., Laatikainen, T., Ylisaukko-Oja, T., Saukkonen, T., & Pietiläinen, K. H. (2021). The association of body mass index with quality of life and working ability: a Finnish population-based study. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, . https://doi.org/10.1007/s11136-021-02993-0
Vesikansa, Aino, et al. "The association of body mass index with quality of life and working ability: a Finnish population-based study." Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation vol. (2021). doi: https://doi.org/10.1007/s11136-021-02993-0
Vesikansa A, Mehtälä J, Jokelainen J, Mutanen K, Lundqvist A, Laatikainen T, Ylisaukko-Oja T, Saukkonen T, Pietiläinen KH. The association of body mass index with quality of life and working ability: a Finnish population-based study. Qual Life Res. 2021 Sep 17; doi: 10.1007/s11136-021-02993-0. Epub 2021 Sep 17. PMID: 34533758.
Copy Download .nbib Format: NLM
Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study.

Open heart

Keto J, Ventola H, Jokelainen J, Linden K, Keinänen-Kiukaanniemi S, Timonen M, Ylisaukko-Oja T, Auvinen J.
PMID: 27493759
Open Heart. 2016 Jul 12;3(2):e000358. doi: 10.1136/openhrt-2015-000358. eCollection 2016.

OBJECTIVE: To investigate how individual risk factors for cardiovascular disease (CVD) (blood pressure, lipid levels, body mass index, waist and hip circumference, use of antihypertensive or hypolipidemic medication, and diagnosed diabetes) differ in people aged 46 years with different...

Cite
Keto J, Ventola H, Jokelainen J, et al. Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study. Open Heart. 2016;3(2):e000358doi: 10.1136/openhrt-2015-000358.
Keto, J., Ventola, H., Jokelainen, J., Linden, K., Keinänen-Kiukaanniemi, S., Timonen, M., Ylisaukko-Oja, T., & Auvinen, J. (2016). Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study. Open heart, 3(2), e000358. https://doi.org/10.1136/openhrt-2015-000358
Keto, Jaana, et al. "Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study." Open heart vol. 3,2 (2016): e000358. doi: https://doi.org/10.1136/openhrt-2015-000358
Keto J, Ventola H, Jokelainen J, Linden K, Keinänen-Kiukaanniemi S, Timonen M, Ylisaukko-Oja T, Auvinen J. Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study. Open Heart. 2016 Jul 12;3(2):e000358. doi: 10.1136/openhrt-2015-000358. eCollection 2016. PMID: 27493759; PMCID: PMC4947752.
Copy Download .nbib Format: NLM
Dose-escalation of adalimumab, golimumab or ustekinumab in inflammatory bowel diseases: characterization and implications in real-life clinical practice.

Scandinavian journal of gastroenterology

Ylisaukko-Oja T, Puttonen M, Jokelainen J, Koivusalo M, Tamminen K, Torvinen S, Voutilainen M.
PMID: 34927504
Scand J Gastroenterol. 2021 Dec 19;1-9. doi: 10.1080/00365521.2021.2014950. Epub 2021 Dec 19.

OBJECTIVES: Dose-escalation is a common practice to optimize treatment with subcutaneously administered biologicals in Crohn's disease (CD) and ulcerative colitis (UC). However, limited data is available on the extent of dose-escalation in real-life. Here, we analyzed treatment persistence, dose-escalation,...

Cite
Ylisaukko-Oja T, Puttonen M, Jokelainen J, et al. Dose-escalation of adalimumab, golimumab or ustekinumab in inflammatory bowel diseases: characterization and implications in real-life clinical practice. Scand J Gastroenterol. 2021;1-9doi: 10.1080/00365521.2021.2014950.
Ylisaukko-Oja, T., Puttonen, M., Jokelainen, J., Koivusalo, M., Tamminen, K., Torvinen, S., & Voutilainen, M. (2021). Dose-escalation of adalimumab, golimumab or ustekinumab in inflammatory bowel diseases: characterization and implications in real-life clinical practice. Scandinavian journal of gastroenterology, 1-9. https://doi.org/10.1080/00365521.2021.2014950
Ylisaukko-Oja, Tero, et al. "Dose-escalation of adalimumab, golimumab or ustekinumab in inflammatory bowel diseases: characterization and implications in real-life clinical practice." Scandinavian journal of gastroenterology vol. (2021): 1-9. doi: https://doi.org/10.1080/00365521.2021.2014950
Ylisaukko-Oja T, Puttonen M, Jokelainen J, Koivusalo M, Tamminen K, Torvinen S, Voutilainen M. Dose-escalation of adalimumab, golimumab or ustekinumab in inflammatory bowel diseases: characterization and implications in real-life clinical practice. Scand J Gastroenterol. 2021 Dec 19;1-9. doi: 10.1080/00365521.2021.2014950. Epub 2021 Dec 19. PMID: 34927504.
Copy Download .nbib Format: NLM
Showing 1 to 3 of 3 entries